SureTrader SureTrader
Home > Boards > US OTC > Cannabis >

Cannabics Pharmaceuticals Inc. (CNBX)

Add CNBX Price Alert      Hide Sticky   Hide Intro
Moderator: captainscotty, WallyWest
Search This Board:
Last Post: 1/15/2017 10:12:17 PM - Followers: 47 - Board type: Free - Posts Today: 0


U.S OFFICE: , 3 BETHESDA METRO CENTRE, BETHESDA, MARYLAND, 20814(877) 424-2429[email protected]


Cannabics Pharmaceuticals is dedicated to the development of Personalized Anti-Cancer treatments.

Our main focus is the development of novel therapies and biotechnological tools aimed to providing relief from diverse ailments and treat human malignancies. These advanced tools include novel delivery systems, personalized medicine diagnostics and therapies based on Cannabinoid compounds.

Cannabics scientific research is devoted to create tailored therapies for cancer patients, utilizing advanced High-throughput screening (HTS) diagnostics and personalized bioinformatics tools.

The Company’s principal product is Cannabics SR' a long acting oil capsule that provides a safe, effective and reliable administration of cannabis. Composed solely from food grade materials, Cannabics SR' 5-10mg delivers a steady level of beneficial effects for 4–8 hours.

Cannabics Pharmaceuticals Inc. is traded in the US OTC stock exchange, under the trade symbol: CNBX


October 20, 2016 Cannabics Pharmaceuticals Discovers Specific Ratios of THC/CBD Effectuate Reduction in U87MG Glioblastoma Cell Viability

September 28, 2016 How this tiny Middle Eastern nation came to lead the world in medical marijuana research

June 6, 2016, Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System.


"Cannabics SR', is a long acting oil capsule that provides a safe, effective and reliable administration of cannabis."


Cannabics SR' Capsules, Technology Description - Route of administration


There is a growing number of patients, worldwide, who could benefit from the therapeutic properties of cannabinoids. The unmet need of these patients is a safe, standardized and easy to administer cannabinoid-based therapy. Cannabinoid administration is mainly through smoking, vaporizing, sublingual and oral. While clinical studies show contradictory data regarding a correlation between smoking cannabis and respiratory diseases, most physicians agree that smoking medical cannabis, while having its benefits, is not a healthy nor standardized therapy. 

The pharmacokinetics of THC varies as a function of its route of administration. Pulmonary assimilation of inhaled THC causes a maximum plasma concentration within minutes; psychotropic effects start within seconds to a few minutes, reach a maximum after 15–30 minutes, and taper off within 2–3 hours. Following oral ingestion, psychotropic effects set in with a delay of 30–90 minutes, reach their maximum after 2–3 hours and last for about 4–12 hours, depending on dose and specific effect. Another common route of administration is sublingually. Pure cannabinoids are extracted from the raw plant, dissolved in different oils and administered with a dropper. The beneficial effect of sublingual oil administration is 2-4 hours with a fast onset due to quick absorption through the oral cavity.

The most common oral administration of cannabinoids is through eating edibles, mainly, cookies, chocolate bars and lozenges. Since absorption is attenuated when cannabinoids are ingested orally, Edibles usually contain high dosages of cannabinoids (50-300mg). The high dosage may cause undesirable side effects, mainly, dizziness, anxiety and dissociation. These side effects cause many patients to withdraw from the therapeutic process.  The oral administration route has the longest beneficial effect (4-8 hours) and lacks the undesirable effects of smoking.

Technology currently envisions the licensing of three different formulations: capsules with a 10:1 CBD to THC ratio, a 10:1 THC to CBD ratio and a balanced formulation with 1:1 THC:CBD.

Cannabics Pharmaceuticals Inc. does not manufacture, distribute, dispense or possess any controlled substances, including cannabis or cannabis based preparations.
CNBX Security Details
Share Structure
  Market Value1 $72,404,107 a/o Jan 13, 2017
Authorized Shares 900,000,000 a/o Dec 30, 2016
Outstanding Shares 107,265,344 a/o Dec 30, 2016
-Restricted 90,368,887 a/o Dec 30, 2016
-Unrestricted 16,896,457 a/o Dec 30, 2016
  Held at DTC Not Available
Float 14,295,638 a/o Jun 30, 2016
  Par Value 0.0001

CNBX Security Details
Share Structure
  Market Value1 $37,994,466 a/o Oct 28, 2016
  Authorized Shares 900,000,000 a/o Jul 09, 2015
  Outstanding Shares 107,026,665 a/o Jun 30, 2016
  -Restricted Not Available
  -Unrestricted Not Available
  Held at DTC Not Available
  Float 18,737,071 a/o Jun 30, 2016
  Par Value 0.0001

Cannabics Pharmaceuticals Inc. is a US based company founded in 2012 by Israeli researchers from the fields of molecular biology and cancer.
The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids and to create tailored therapies for cancer patients, utilizing advanced HTS technology and personalized bioinformatics tools.
The Company's R&D is based in Israel, where it is fully licensed by The Ministry of Health and involves both scientific and academic research as well as current ongoing medical clinical studies which are registered with the US NIH.

The Company new clinical study examine the effectiveness of Cannabics SR capsules as treatment to improve cancer related CACS (Cachexia and Anorexia) in advanced cancer Patients. While this study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", identifier NCT02359123 and can be found at:

What is A Cannabinoid?

You’ve heard by now that marijuana is a powerful medicinal herb. But, just how powerful is it? The list of medical benefits for these top 10 cannabinoids seems endless.


Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome...!

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.

Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at :

"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc." style="height:398px; width:400px">


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CNBX News: Report of Proposed Sale of Securities (144) 12/21/2016 02:05:02 PM
CNBX News: Annual Report (10-k) 12/13/2016 01:59:15 PM
CNBX News: Current Report Filing (8-k) 12/13/2016 01:55:24 PM
CNBX News: Notification That Annual Report Will Be Submitted Late (nt 10-k) 11/29/2016 10:07:42 AM
#568  Sticky Note Cannabics Pharmaceuticals Announces a New Dosage of 5mg captainscotty 01/15/17 09:13:10 PM
#569   #CNBX: Hey Midnight got any more great news? captainscotty 01/15/17 10:12:17 PM
#568   Cannabics Pharmaceuticals Announces a New Dosage of 5mg captainscotty 01/15/17 09:13:10 PM
#567   #CNBX:Yes Vinsky Dollarland is coming back times 4...:-] captainscotty 01/15/17 08:47:22 PM
#566 captainscotty 01/15/17 08:36:52 PM
#565   I see a rise of 100% sure. jpowellvlc 01/15/17 05:01:42 AM
#564   Wow great prediction . I see much thought gsobes 01/14/17 04:45:09 PM
#563   #CNBX:Great base building at MA 20 = 0.68...:-} captainscotty 01/14/17 10:32:03 AM
#562   Big move comming ..from 0.66 to 0.33 and jpowellvlc 01/14/17 07:40:52 AM
#561 Midnightmatt 01/06/17 06:45:50 PM
#560   Thank You captainscotty! I subscribed. jim992 01/06/17 04:12:19 PM
#559   #CNBX:Check this out FOLKS ! captainscotty 01/06/17 07:51:55 AM
#558   This was posted on E-Trade and at CNBX jim992 01/04/17 03:45:03 PM
#557   Is this a "gut feeling forecast" or is jim992 12/30/16 01:43:39 AM
#556   #CNBX: Looking for $4.00 by 04-01-2016 captainscotty 12/29/16 10:53:45 PM
#555   #CNBX:Loading under 0.49 Vinsky..Going to $4.00 in 2017..:-} captainscotty 12/26/16 08:34:45 AM
#554   $CNBX $1 soon again :-) I think vinsky_ever_trader 12/22/16 07:47:30 AM
#553   U.S. National Cancer Institute admits Cannabis kills Cancer! Black Solvency 12/21/16 11:36:53 PM
#552   Black Solvency re-entered CNBX .46-.47 x 10k, WOW! Black Solvency 12/21/16 03:53:00 PM
#551   $CNBX adding nice :-) vinsky_ever_trader 12/21/16 03:03:41 PM
#550   what a scam this turned stockzoom 12/21/16 02:50:15 PM
#549   You got scammed !!!!!! see ya at 20 stockzoom 12/21/16 02:37:41 PM
#548   I hear you. I'm staying put and grabbing Midnightmatt 12/21/16 07:38:33 AM
#547   Thank You for the article MidnightMatt. jim992 12/20/16 03:56:23 PM
#546   Thank You for the article MidnightMatt. jim992 12/20/16 03:55:44 PM
#545 Midnightmatt 12/20/16 12:05:51 PM
#544   One of the most promising things I gleaned jim992 12/19/16 04:05:42 PM
#543   So is Uri Ben-Or, with his years of jim992 12/19/16 01:19:10 PM
#542 Midnightmatt 12/15/16 05:14:44 PM
#541   You guys are the best. Thanks for the Midnightmatt 12/15/16 02:24:37 AM
#540   I was trying to find the latest 10Q jim992 12/15/16 01:34:18 AM
#539   I think that little snippet they released earlier realnewb 12/14/16 06:23:46 PM
#538   Hi Midnightmatt, jim992 12/14/16 04:47:14 PM
#537   I was wondering the same thing about this Midnightmatt 12/14/16 01:29:26 AM
#536   Hi Everyone. I have enjoyed following here jim992 12/13/16 03:31:21 PM
#535   $CNBX Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Cancer PennyStockGang 12/07/16 09:42:06 AM
#534   DD shows otherwise... please provide any record of realnewb 12/06/16 09:59:53 PM
#533   Nice lol. I'm still here just lurking in realnewb 12/06/16 11:49:07 AM
#532   CNBX bullish 0.91 stocktrademan 12/06/16 10:51:07 AM
#531   link please for any of the above onco 12/06/16 10:49:48 AM
#530   very nice for a Tuesday!! TrendTrade2016 12/06/16 10:14:07 AM
#529   Was wondering what happened to you homie! Thought Midnightmatt 12/05/16 09:13:48 PM
#528   back in here to follow axim TrendTrade2016 12/05/16 06:19:27 PM
#527   Silence is golden :) realnewb 12/05/16 01:21:17 PM
#526   What's good dude!! I saw this morning. realnewb 12/02/16 03:45:39 PM
#525   I have no idea what you're talking about. WallyWest 12/02/16 01:52:28 PM
#524   the stock and company has issues than a hwyrider 12/02/16 11:06:32 AM
#523   Realnewb, check out that news on Yahoo today. Midnightmatt 12/01/16 09:59:07 AM
#522   Owcp is great too! There's a few of realnewb 12/01/16 09:48:38 AM
#521   curious why posting stopped here...anyone have an opinion Mandofellow 11/30/16 02:40:23 PM
#520   #CNBX: Could be headed for a double bottom soon..:-] captainscotty 11/28/16 04:48:39 PM